Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Preliminary results
Quarterly results
Director departure
Appointed director
CC transcript
Alexza Pharmaceuticals Inc. (ALXA) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/16/2018 CT ORDER Form CT ORDER - Confidential treatment order:
01/16/2018 CT ORDER Form CT ORDER - Confidential treatment order:
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
03/31/2017 CT ORDER Form CT ORDER - Confidential treatment order
07/15/2016 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/08/2016 EFFECT Form EFFECT - Notice of Effectiveness
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
07/05/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
07/05/2016 POS AM Form POS AM - Post-Effective amendments for registration statement
07/05/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
07/01/2016 8-K Quarterly results
06/24/2016 8-K Form 8-K - Current report
06/22/2016 4 Grupo Ferrer Internacional, S.A. (10% Owner) has filed a Form 4 on Alexza Pharmaceuticals Inc.
Txns: Bought 19,465,714 shares @ $0.9, valued at $17.5M
06/21/2016 4 Kamemoto Edwin S (EVP, R&D, Regulatory & Quality) has filed a Form 4 on Alexza Pharmaceuticals Inc.
Txns: Unknown transaction of 9,112 shares @ $0
Disposed/sold 125,000 options to buy @ $1.08, valued at $135k
Disposed/sold 35,000 options to buy @ $1.95, valued at $68.3k
Disposed/sold 15,000 options to buy @ $3.47, valued at $52.1k
Disposed/sold 5,000 options to buy @ $3.47, valued at $17.4k
Disposed/sold 43,750 options to buy @ $4.42, valued at $193.4k
Disposed/sold 24,000 options to buy @ $4.57, valued at $109.7k
Disposed/sold 9,999 options to buy @ $15.3, valued at $153k
06/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2016 4 TURNER JOSEPH L (Director) has filed a Form 4 on Alexza Pharmaceuticals Inc.
06/21/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy